SAN ANTONIO, Oct. 16, 2013 /PRNewswire/ -- BME, Inc. (BioMedical Enterprises, Inc., www.bme-tx.com) is the privately held U.S. leader in shape memory technology for small bone fixation. BME is the first US-based manufacturer of Nitinol Implants and Instruments for use in the foot, hand and wrist. Marketed under the brands: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), BME has announced today the introduction of the new Speed™ Shift™ Continuous Active Compression System.
The Speed Shift Continuous Active Compression System is the world's FIRST superelastic Nitinol bone fixation implant with an offset bridge to accommodate uneven bone surfaces that are procedure specific, such as for sliding calcaneal osteotomies. This unique superelastic implant, with a stepped bridge (available in a range of sizes from 4mm to 12mm) offers the Foot & Ankle surgeon intraoperative options for reconstruction of flatfoot and high arch conditions.
The new Speed Shift System is a patent-pending, fully disposable, pre-sterilized implant & instrumentation system that includes the newly released patent-pending Speed™ Zero-Torque™ Insertion Tool. The Shift offset implant, which comes pre-loaded onto the Speed Zero-Torque Insertion Tool, offers our customers more options.
Keith M. Peeples, President & CEO of BME, had this to say to analysts: "BME continues to drive innovation in the area of Nitinol Shape Memory. With the medical communities' expectation to improve product reliability and performance, BME is setting new industry standards for improved surgical performance for shape memory fixation. Our mission is to design and manufacture implants that significantly enhance the healing of bone without compromise. BME stands committed to continue offering easy, fast, reproducible and cost effective implants and instruments to our hospitals, surgeons and their patients."
The new BME Speed Shift Continuous Active Compression System will be available for commercial use throughout the United States October 21, 2013.
About BME, Inc.
BME, Inc. is the only U.S. manufacturer of Nitinol metal implants for musculoskeletal and soft tissue fixation. For over a decade, BME has spearheaded the innovation of the Nitinol technologies in the U.S. market, and continues the advancement of Nitinol implants and instruments. This is accomplished by BME developing new standards for manufacturing processes, defining new clinical parameters for product development, adding to its surgeon advisory boards, and focusing on the education of our surgeon communities on the clinical benefits of the Nitinol technology. Innovation and strategic partnerships will further define the role of BME as leaders as demonstrated in our commitment to the BME surgeon and his patients.
SOURCE BME, Inc.